重视促排卵的质量与安全性

被引:12
作者
乔杰
张曜耀
李蓉
机构
[1] 北京大学第三医院妇产科生殖医学中心
关键词
辅助生殖技术; 促排卵; 卵子质量; 安全性;
D O I
暂无
中图分类号
R714.8 [];
学科分类号
摘要
促排卵治疗是决定辅助生殖成功率的关键步骤,随着促排卵药物的大量应用,促排卵治疗方式的选择及并发症带来的风险也日益受到关注。这一领域需要更多的大样本、多中心临床研究和动物试验研究,以此指导促排卵的临床合理应用。
引用
收藏
页码:13 / 17
页数:5
相关论文
共 25 条
[1]
Cryopréservation de la cohorte embryonnaire en cas de risque d’hyperstimulation : prévention et efficacité.[J].P. Massart;N. Sermondade;C. Dupont;C. Sifer;I. Cedrin-Durnerin;J.N. Hugues.Gynécologie Obstétrique & Fertilité.2013, 6
[2]
Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study [J].
Konig, T. E. ;
van der Houwen, L. E. E. ;
Overbeek, A. ;
Hendriks, M. L. ;
Beutler-Beemsterboer, S. N. ;
Kuchenbecker, W. K. H. ;
Renckens, C. N. M. ;
Bernardus, R. E. ;
Schats, R. ;
Homburg, R. ;
Hompes, P. G. A. ;
Lambalk, C. B. .
HUMAN REPRODUCTION, 2013, 28 (10) :2804-2812
[3]
Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles [J].
Wu, Ze ;
Li, Rong ;
Ma, Yanping ;
Deng, Bo ;
Zhang, Xiaomei ;
Meng, Yushi ;
Chen, Xinna ;
Liu, Ping ;
Qiao, Jie .
REPRODUCTIVE BIOMEDICINE ONLINE, 2012, 24 (05) :511-520
[4]
The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis [J].
Hill, Micah J. ;
Levens, Eric D. ;
Levy, Gary ;
Ryan, Mary E. ;
Csokmay, John M. ;
DeCherney, Alan H. ;
Whitcomb, Brian W. .
FERTILITY AND STERILITY, 2012, 97 (05) :1108-+
[5]
Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective [J].
Wong, Peng Cheang ;
Qiao, Jie ;
Ho, Clement ;
Ramaraju, Gottumukkala A. ;
Wiweko, Budi ;
Takehara, Yuji ;
Nadkarni, Prashant V. ;
Cheng, Li-Chang ;
Chen, Hsin-Fu ;
Suwajanakorn, Somchai ;
Thi Ngoc Lan Vuong .
REPRODUCTIVE BIOMEDICINE ONLINE, 2011, 23 (01) :81-90
[6]
Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization [J].
Kovacs, Peter ;
Kovats, Timea ;
Kaali, Steven G. .
FERTILITY AND STERILITY, 2010, 93 (02) :475-479
[7]
Are gonadotropin-releasing hormone agonists losing popularity? Current trends at a large fertility center [J].
Reh, Andrea ;
Krey, Lewis ;
Noyes, Nicole .
FERTILITY AND STERILITY, 2010, 93 (01) :101-108
[8]
Benefits of luteinizing hormone activity in ovarian stimulation for IVF.[J].CA Venetis;EM Kolibianakis;TB Tarlatzi;BC Tarlatzis.Reproductive BioMedicine Online.2009,
[9]
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer [J].
Dauplat, J. ;
Chene, G. ;
Pomel, C. ;
Dauplat, M. M. ;
Le Bouedec, G. ;
Mishellany, F. ;
Lagarde, N. ;
Bignon, Y. J. ;
Jaffeux, P. ;
Aublet-Cuvelier, B. ;
Dechelotte, P. ;
Pouly, J. L. ;
Penault-Llorca, F. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (17) :2977-2983
[10]
Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden [J].
Sanner, Karin ;
Conner, Peter ;
Bergfeldt, Kjell ;
Dickman, Paul ;
Sundfeldt, Karin ;
Bergh, Torbjorn ;
Hagenfeldt, Kerstin ;
Janson, Per Olof ;
Nilsson, Staffan ;
Persson, Ingemar .
FERTILITY AND STERILITY, 2009, 91 (04) :1152-1158